New drug shows strong results against stubborn mutation

June 5, 2019 | Michael Easterling

A new drug being investigated by Marwan Fakih, M.D., professor in the Department of Medical Oncology & Therapeutics Research and medical director of the Judy & Bernard Briskin Center for Clinical Research, is "potentially practice-changing," Fakih said.

Continue Reading

Super cells could help doctors detect cancer seven years sooner

July 18, 2019 | Maxine Nunes

Tiny molecular "packages" can be harnessed for diagnosis and treatment of cancer, diabetes and other diseases, City of Hope researchers are discovering.

Study: A1c test misses most cases

June 13, 2019 | City of Hope

The hemoglobin A1c blood test is widely used to diagnose type 1 and type 2 diabetes but it is actually unable to detect the disease in most patients, according to a new study presented March 23 at the Endocrine Society’s annual meeting.

International diabetes experts converge for Levine-Riggs symposium

April 23, 2019 | Michael Easterling

More than 250 physicians and scientists from around the world attended the 2019 City of Hope Levine-Riggs Diabetes Research Symposium, held April 10 to 13 at The Westin Hotel in Pasadena, California.

City of Hope study finds diabetes A1c test misses most cases

March 28, 2019 | City of Hope

The hemoglobin A1c blood test is widely used to diagnose type 1 and type 2 diabetes but it is actually unable to detect the disease in most patients, according to a new study presented March 23 at the Endocrine Society’s annual meeting.

Study by diabetes expert describes promising type 1 treatments

February 14, 2019 | Katie Neith

A paper co-authored by Bart Roep, Ph.D., Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes and the founding chair of the Department of Diabetes Immunology at City of Hope, published in Nature explores new ways of replacing beta cells after too many of them have been killed by the immune system.